The dark side of Nrf2

World Neurosurgery

Volumn 80, Issue 3-4, 2013, Pages 284-286

  Grossman, Rachel ^a   Ram, Zvi ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Glioma; Invasion; Matrix metalloproteinase 9; Migration; NF E2 related factor 2

Indexed keywords

ARSENIC TRIOXIDE; CISPLATIN; GELATINASE B; HEME OXYGENASE 1; PACLITAXEL; TRANSCRIPTION FACTOR NRF2;

CELL INVASION; CELL MIGRATION; EDEMA; ENDOMETRIUM CARCINOMA; GLIOMA CELL; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; SPINAL CORD INJURY; UPREGULATION;

EID: 84885180631     PISSN: 18788750     EISSN: 18788769     Source Type: Journal    
DOI: 10.1016/j.wneu.2011.09.055     Document Type: Article

References (25)

1. Y. Aoki, H. Sato, N. Nishimura, S. Takahashi, K. Itoh, and M. Yamamoto Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust Toxicol Appl Pharmacol 173 2001 154 160
2. F.J. Attenello, D. Mukherjee, G. Datoo, M.J. McGirt, E. Bohan, J.D. Weingart, A. Olivi, A. Quinones-Hinojosa, and H. Brem Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience Ann Surg Oncol 15 2008 2887 2893
3. G. Choe, J.K. Park, L. Jouben-Steele, T.J. Kremen, L.M. Liau, H.V. Vinters, T.F. Cloughesy, and P.S. Mischel Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype Clin Cancer Res 8 2002 2894 2901
4. J.F. de Groot, G. Fuller, A.J. Kumar, Y. Piao, K. Eterovic, Y. Ji, and C.A. Conrad Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice Neuro Oncol 12 2010 233 242
5. A.T. Dinkova-Kostova, W.D. Holtzclaw, R.N. Cole, K. Itoh, N. Wakabayashi, Y. Katoh, M. Yamamoto, and P. Talalay Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants Proc Natl Acad Sci U S A 99 2002 11908 11913
6. J.W. Fahey, X. Haristoy, P.M. Dolan, T.W. Kensler, I. Scholtus, K.K. Stephenson, P. Talalay, and A. Lozniewski Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors Proc Natl Acad Sci U S A 99 2002 7610 7615
7. P.A. Forsyth, H. Wong, T.D. Laing, N.B. Rewcastle, D.G. Morris, H. Muzik, K.J. Leco, R.N. Johnston, P.M. Brasher, G. Sutherland, and D.R. Edwards Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas Br J Cancer 79 1999 1828 1835
8. D.A. Frohlich, M.T. McCabe, R.S. Arnold, and M.L. Day The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis Oncogene 27 2008 4353 4362
9. K. Iida, K. Itoh, Y. Kumagai, R. Oyasu, K. Hattori, K. Kawai, T. Shimazui, H. Akaza, and M. Yamamoto Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis Cancer Res 64 2004 6424 6431
10. K. Iida, K. Itoh, J.M. Maher, Y. Kumagai, R. Oyasu, Y. Mori, T. Shimazui, H. Akaza, and M. Yamamoto Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis Carcinogenesis 28 2007 2398 2403
11. T. Jiang, N. Chen, F. Zhao, X.J. Wang, B. Kong, W. Zheng, and D.D. Zhang High levels of Nrf2 determine chemoresistance in type II endometrial cancer Cancer Res 70 2010 5486 5496
12. W. Jin, H. Wang, W. Yan, L. Xu, X. Wang, X. Zhao, X. Yang, G. Chen, and Y. Ji Disruption of Nrf2 enhances upregulation of nuclear factor-kappaB activity, proinflammatory cytokines, and intercellular adhesion molecule-1 in the brain after traumatic brain injury Mediators Inflamm 2008 2008 725174
13. C. Lee, G.H. Park, and J.H. Jang Cellular antioxidant adaptive survival response to 6-hydroxydopamine-induced nitrosative cell death in C6 glioma cells Toxicology 283 2011 118 128
14. J. Li, T.D. Stein, and J.A. Johnson Genetic dissection of systemic autoimmune disease in Nrf2-deficient mice Physiol Genomics 18 2004 261 272
15. Y. Liu, Y. Liang, T. Zheng, G. Yang, X. Zhang, Z. Sun, C. Shi, and S. Zhao Inhibition of heme oxygenase-1 enhances anti-cancer effects of arsenic trioxide on glioma cells J Neurooncol 104 2011 449 458
16. L. Mao, H. Wang, L. Qiao, and X. Wang Disruption of Nrf2 enhances the upregulation of nuclear factor-kappaB activity, tumor necrosis factor-alpha, and matrix metalloproteinase-9 after spinal cord injury in mice Mediators Inflamm 2010 2010 238321
17. G. Rachakonda, K.R. Sekhar, D. Jowhar, P.C. Samson, J.P. Wikswo, R.D. Beauchamp, P.K. Datta, and M.L. Freeman Increased cell migration and plasticity in Nrf2-deficient cancer cell lines Oncogene 29 2010 3703 3714
18. M. Ramos-Gomez, M.K. Kwak, P.M. Dolan, K. Itoh, M. Yamamoto, P. Talalay, and T.W. Kensler Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice Proc Natl Acad Sci U S A 98 2001 3410 3415
19. N.M. Reddy, S.R. Kleeberger, J.H. Bream, P.G. Fallon, T.W. Kensler, M. Yamamoto, and S.P. Reddy Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling Oncogene 27 2008 5821 5832
20. R. Roy, J. Yang, and M.A. Moses Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer J Clin Oncol 27 2009 5287 5297
21. E.R. Smith, D. Zurakowski, A. Saad, R.M. Scott, and M.A. Moses Urinary biomarkers predict brain tumor presence and response to therapy Clin Cancer Res 14 2008 2378 2386
22. D.R. Stacy, K. Ely, P.P. Massion, W.G. Yarbrough, D.E. Hallahan, K.R. Sekhar, and M.L. Freeman Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas Head Neck 28 2006 813 818
23. X.J. Wang, Z. Sun, N.F. Villeneuve, S. Zhang, F. Zhao, Y. Li, W. Chen, X. Yi, W. Zheng, G.T. Wondrak, P.K. Wong, and D.D. Zhang Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2 Carcinogenesis 29 2008 1235 1243
24. C. Xu, M.T. Huang, G. Shen, X. Yuan, W. Lin, T.O. Khor, A.H. Conney, and A.N. Kong Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2 Cancer Res 66 2006 8293 8296
25. S. Yu, and A.N. Kong Targeting carcinogen metabolism by dietary cancer preventive compounds Curr Cancer Drug Targets 7 2007 416 424